Home The Word Brain	My Amedeo FAQ Privacy About
	C49 In our changing world, speaking just English isn't enough. Open new doors with skills in another world language. Start with 7 words a day. Next week: +49.

Contraception and Contraceptive Drugs

Free Subscription Articles published in Contraception Retrieve available abstracts of 224 articles: HTML format

Single Articles

June 2025
1. NAGTALON-RAMOS J, Saffold TL, Pontes N, Pontes M, et al
   Race-ethnicity and sex disparities in the use of pregnancy prevention methods among U.S. high school students.
   Contraception. 2025;146:110857.
   PubMed     Abstract available
   
   
   
2. MASTEN M, Kathawa C, Shiferaw T, Clure C, et al
   Dilation and evacuation in the setting of trachelectomy and abdominal cerclage: A case report and review of the literature.
   Contraception. 2025;146:110840.
   PubMed     Abstract available
   
   
   May 2025
3. NOURSE SE, Woodcock AL, Brown KS, Gero A, et al
   Estimating emergency contraception efficacy with levonorgestrel and copper intrauterine devices.
   Contraception. 2025 May 12:110946. doi: 10.1016/j.contraception.2025.110946.
   PubMed     Abstract available
   
   
   
4. TEPPER NK, Nguyen AT, Curtis KM, Baumhart C, et al
   Thrombosis risk with use of hormonal contraception among women with thrombophilia: an updated systematic review.
   Contraception. 2025 May 9:110943. doi: 10.1016/j.contraception.2025.110943.
   PubMed     Abstract available
   
   
   
5. SERRANO MG, Edwards D, Ahmed K, Bailey VC, et al
   Effect of contraceptive methods on the vaginal microbiome and host immune factors.
   Contraception. 2025 May 7:110936. doi: 10.1016/j.contraception.2025.110936.
   PubMed     Abstract available
   
   
   
6. GAWRON LM, Sexsmith CD, Carter G, Kaiser JE, et al
   One-year continuation of the etonogestrel contraceptive implant initiated with oral emergency contraception.
   Contraception. 2025 May 7:110938. doi: 10.1016/j.contraception.2025.110938.
   PubMed     Abstract available
   
   
   
7. CHUNG S, Bullington B, Goland E, Onyango DO, et al
   Provider-imposed restrictions on contraceptive use in Western Kenya.
   Contraception. 2025 May 7:110937. doi: 10.1016/j.contraception.2025.110937.
   PubMed     Abstract available
   
   
   
8. MATSUMOTO NM, Chiartas TG, Paysour BR, Barry TJ, et al
   Preclinical development of a novel injectable hydrogel for vas-occlusion.
   Contraception. 2025;145:110839.
   PubMed     Abstract available
   
   
   April 2025
9. GIPSON JD, Bornstein M, Duong A, Nguyen BT, et al
   Motivations to use a novel hormonal male contraceptive: Perspectives from male contraceptive clinical trial participants.
   Contraception. 2025 Apr 30:110932. doi: 10.1016/j.contraception.2025.110932.
   PubMed     Abstract available
   
   
   
10. SWARTZ JJ, Truong T, Rodriguez MI, Swamy GK, et al
    Future reproductive outcomes and contraceptive access in the first year postpartum after non-receipt of postpartum permanent contraception.
    Contraception. 2025 Apr 29:110933. doi: 10.1016/j.contraception.2025.110933.
    PubMed     Abstract available
    
    
    
11. MAGER ND, Hageman TS, Bright DR
    Pharmacy Deserts: A Complexity That Worsens Contraception Access in the United States.
    Contraception. 2025 Apr 23:110931. doi: 10.1016/j.contraception.2025.110931.
    PubMed    
    
    
    
12. STEINER RJ, Axelson SM, Nunez-Eddy C, Williams K, et al
    Knowledge Gaps and Information Needs and Preferences Regarding Oral Contraceptive Pills and Over-the-Counter Access: A Focus Group Study with Black and Latinx Young People Assigned Female at Birth.
    Contraception. 2025 Apr 9:110900. doi: 10.1016/j.contraception.2025.110900.
    PubMed     Abstract available
    
    
    
13. SNYDER EM, Curtis KM, Nguyen AT, Tadikonda A, et al
    Hormonal Contraception after Use of Ulipristal Acetate as Emergency Contraception: A Systematic Review.
    Contraception. 2025 Apr 3:110898. doi: 10.1016/j.contraception.2025.110898.
    PubMed     Abstract available
    
    
    March 2025
14. BATUR P, Brant A, McCourt C, Schwarz EB, et al
    Society of Family Planning Committee Statement: Contraceptive considerations for individuals with cancer and cancer survivors part 1 - Key considerations for clinical care Joint with the Society of Gynecologic Oncology.
    Contraception. 2025 Mar 27:110870. doi: 10.1016/j.contraception.2025.110870.
    PubMed     Abstract available
    
    
    
15. BATUR P, Brant A, McCourt C, Schwarz EB, et al
    Society of Family Planning Clinical Recommendation: Contraceptive considerations for individuals with cancer and cancer survivors part 2 - Breast, ovarian, uterine, and cervical cancer.
    Contraception. 2025 Mar 27:110867. doi: 10.1016/j.contraception.2025.110867.
    PubMed     Abstract available
    
    
    
16. BATUR P, Brant A, McCourt C, Schwarz EB, et al
    Society of Family Planning Clinical Recommendation: Contraceptive considerations for individuals with cancer and cancer survivors part 3 - Skin, blood, gastrointestinal, liver, lung, central nervous system, and other cancers: Joint with the Society of
    Contraception. 2025 Mar 27:110869. doi: 10.1016/j.contraception.2025.110869.
    PubMed     Abstract available
    
    
    
17. EBERSOLE AM, Liberty A, Edelman A, Lyman E, et al
    Uses of ulipristal acetate beyond emergency contraception: a narrative review.
    Contraception. 2025 Mar 3:110862. doi: 10.1016/j.contraception.2025.110862.
    PubMed     Abstract available
    
    
    
18. NELSON HN, Sugarman R, Wong ML
    Hemiplegic migraine associated with etonogestrel 68 mg implant insertion case report.
    Contraception. 2025;143:110783.
    PubMed     Abstract available
    
    
    February 2025
19. HORVATH S, Guare EG, Ferguson G, Chuang CH, et al
    Pennsylvania Medicaid policy and rural hospital implementation of immediate postpartum contraception.
    Contraception. 2025 Feb 27:110858. doi: 10.1016/j.contraception.2025.110858.
    PubMed     Abstract available
    
    
    
20. SETHASINE S, Suthasmalee S, Tangjitgamol S, Phaloprakarn C, et al
    Contraception and nonalcoholic fatty liver disease in women with prior gestational diabetes mellitus.
    Contraception. 2025 Feb 26:110860. doi: 10.1016/j.contraception.2025.110860.
    PubMed     Abstract available
    
    
    
21. BEGG L, Sailer J, Risse K, Danna K, et al
    The International Contraceptive Access Foundation's Model for Improving Access to the Hormonal Intrauterine Device.
    Contraception. 2025 Feb 22:110854. doi: 10.1016/j.contraception.2025.110854.
    PubMed     Abstract available
    
    
    
22. WOOFTER R, Patil R, Sudhinaraset M, Gipson J, et al
    Long-acting reversible contraceptive preference and initiation among clinic-based and telemedicine medication abortion patients at one academic health system in California.
    Contraception. 2025 Feb 10:110838. doi: 10.1016/j.contraception.2025.110838.
    PubMed     Abstract available
    
    
    
23. FELIX-FAURE C, Coombe J, Williams H, Caddy C, et al
    What do Australian contraceptive users say about their experience of having an intrauterine device inserted? Findings from an online, qualitative survey.
    Contraception. 2025 Feb 7:110836. doi: 10.1016/j.contraception.2025.110836.
    PubMed     Abstract available
    
    
    
24. MILANKO NA, Gangaram R
    Symptomatic hypotensive episodes following Implanon NXT insertion: A case report.
    Contraception. 2025;142:110730.
    PubMed     Abstract available
    
    
    
25. DIDEMBOURG M, Locquet M, Raskin L, Tchimchoua BT, et al
    Lower reporting of venous thromboembolisms events with natural estrogen-based combined oral contraceptives compared to ethinylestradiol-containing pills: A disproportionality analysis of the Eudravigilance database.
    Contraception. 2025;142:110727.
    PubMed     Abstract available
    
    
    
26. COMPTON SD, Carter G, Gero A, Sanders JN, et al
    Assessing the impact of federal restrictions to the Title X program on reproductive health service provision between 2018 and 2022 in the United States.
    Contraception. 2025;142:110724.
    PubMed     Abstract available
    
    
    
27. BROWN JA, Yazdani S, Economou N, Rankin HA, et al
    Levonorgestrel 52 mg intrauterine device placement without uterine sounding: A feasibility study.
    Contraception. 2025;142:110722.
    PubMed     Abstract available
    
    
    
28. SUNAGAWA SW, Winchester LC, Wichman CS, Avedissian SN, et al
    Comparison of etonogestrel bioanalytical assay results in plasma and serum within and across laboratories.
    Contraception. 2025;142:110720.
    PubMed     Abstract available
    
    
    
29. BURTON L, Perry R, Jacobson J
    Success of medication abortion with mifepristone followed by two doses of misoprostol in very early pregnancy.
    Contraception. 2025;142:110696.
    PubMed     Abstract available
    
    
    January 2025
30. BREWER C, Nguyen BT
    Web traffic and Google Trends data show increased interest in novel male contraception following the Supreme Court's Dobbs v. Jackson ruling.
    Contraception. 2025 Jan 30:110835. doi: 10.1016/j.contraception.2025.110835.
    PubMed     Abstract available
    
    
    
31. BERNARD C, Edmonds BT, Kean K, Evans R, et al
    The Association of Social Deprivation Index and Contraception Care in a Statewide Contraceptive Access Initiative.
    Contraception. 2025 Jan 30:110833. doi: 10.1016/j.contraception.2025.110833.
    PubMed     Abstract available
    
    
    
32. OLSON H, Kavanaugh ML
    Where do female contraceptive users get their methods, and does this differ by insurance coverage? A state-level examination.
    Contraception. 2025 Jan 30:110834. doi: 10.1016/j.contraception.2025.110834.
    PubMed     Abstract available
    
    
    
33. MACKENZIE ACL, Chung S, Hoppes E, Miller N, et al
    Consensus recommendations for measuring the impact of contraception on the menstrual cycle in contraceptive clinical trials.
    Contraception. 2025 Jan 24:110829. doi: 10.1016/j.contraception.2025.110829.
    PubMed     Abstract available
    
    
    
34. BEARDSWORTH KM, Garg B, Darney BG, Han L, et al
    Association of willingness to use hormonal contraception with knowledge: A national survey.
    Contraception. 2025 Jan 23:110816. doi: 10.1016/j.contraception.2025.110816.
    PubMed     Abstract available
    
    
    
35. SITRUK-WARE R, Blithe DL, Page ST, Wang C, et al
    Development of a transdermal gel for reversible male contraception.
    Contraception. 2025 Jan 23:110830. doi: 10.1016/j.contraception.2025.110830.
    PubMed     Abstract available
    
    
    
36. KIM T, Steinberg JR, Boudreaux M
    Changes in Contraceptive Method Use, Access, and Experiences of Care During a Statewide Contraceptive Initiative.
    Contraception. 2025 Jan 16:110814. doi: 10.1016/j.contraception.2025.110814.
    PubMed     Abstract available
    
    
    
37. HOLT K, Gomez R, Amongin D, Omoluabi E, et al
    Validation of the Contraception-Focused Preference-Aligned Fertility Management Index in Uganda and Nigeria.
    Contraception. 2025 Jan 10:110813. doi: 10.1016/j.contraception.2025.110813.
    PubMed     Abstract available
    
    
    
38. KIDULA N, Nguyen BT, Habib N, Kiarie J, et al
    THE IMPACT OF MALE CONTRACEPTION ON GLOBAL SEXUAL AND REPRODUCTIVE HEALTH AND RIGHTS.
    Contraception. 2025 Jan 7:110811. doi: 10.1016/j.contraception.2025.110811.
    PubMed     Abstract available
    
    
    
39. SHI R, Wolgemuth DJ, Georg GI
    Development of the retinoic acid receptor alpha-specific antagonist YCT-529 for male contraception: A brief review.
    Contraception. 2025 Jan 3:110809. doi: 10.1016/j.contraception.2024.110809.
    PubMed     Abstract available
    
    
    December 2024
40. LEVI EE, Avila K, Wu H
    Immediate postpartum contraceptive implant placement and breastfeeding success in postpartum people at risk for low milk supply: a randomized non-inferiority trial.
    Contraception. 2024 Dec 25:110806. doi: 10.1016/j.contraception.2024.110806.
    PubMed     Abstract available
    
    
    
41. BOEHNKE T, Franke C, Bauerfeind A, Heinemann K, et al
    Impact of progestin type on the risk of drug interactions between combined oral contraceptives and psychotropic drugs: a pooled analysis of real-world data.
    Contraception. 2024 Dec 19:110786. doi: 10.1016/j.contraception.2024.110786.
    PubMed     Abstract available
    
    
    
42. BERRY J, Obedin-Maliver J, Ragosta S, Hastings J, et al
    Healthcare provider communication and current contraceptive use among transgender men and gender-diverse people: results from an online, cross-sectional survey in the United States.
    Contraception. 2024 Dec 17:110784. doi: 10.1016/j.contraception.2024.110784.
    PubMed     Abstract available
    
    
    
43. NANDI P, Lekshmi D, Charles AS, Werner E, et al
    A statewide analysis of uptake of highly effective contraception offered immediately postpartum in Massachusetts, 2017 - 2021.
    Contraception. 2024 Dec 17:110785. doi: 10.1016/j.contraception.2024.110785.
    PubMed     Abstract available
    
    
    
44. BENNINK HJTC
    New Endocrine Method of Oral Male Contraception.
    Contraception. 2024 Dec 12:110782. doi: 10.1016/j.contraception.2024.110782.
    PubMed     Abstract available
    
    
    
45. THORNTON M, Bullington BW, Berg KA, White K, et al
    Patient and OBGYN Perspectives on Considering Long-Acting Reversible Contraception for Postpartum Patients Who Desire Permanent Contraception.
    Contraception. 2024 Dec 4:110781. doi: 10.1016/j.contraception.2024.110781.
    PubMed     Abstract available
    
    
    
46. LIU SM, Henkel A, Meza P, Shorter JM, et al
    Comparing transcervical balloon with osmotic dilators for cervical preparation prior to procedural abortion: A noninferiority randomized trial.
    Contraception. 2024;140:110550.
    PubMed     Abstract available
    
    
    
47. ANGER HA, Raymond EG
    Clinical and service delivery outcomes following medication abortion provided with or without pretreatment ultrasound or pelvic examination: An updated comparative analysis.
    Contraception. 2024;140:110552.
    PubMed     Abstract available
    
    
    
48. KAPP N, Bawah AA, Agula C, Menzel JL, et al
    Medical abortion in Ghana: A non-randomized, non-inferiority study of access through pharmacies compared with clinics.
    Contraception. 2024;140:110538.
    PubMed     Abstract available
    
    
    November 2024
49. RICKER EA, De Souza MJ, Stone MS, Jackson GS, et al
    Differential bone calcium retention with the use of oral versus vaginal hormonal contraception: A randomized trial using calcium-41 radiotracer().
    Contraception. 2024 Nov 28:110778. doi: 10.1016/j.contraception.2024.110778.
    PubMed     Abstract available
    
    
    
50. DARNEY BG, Boniface ER, Riosmena F, Fuentes-Rivera E, et al
    Immigrant policy climates and contraceptive use among Mexican origin women in the US: Support for the "spill-over" hypothesis.
    Contraception. 2024 Nov 21:110773. doi: 10.1016/j.contraception.2024.110773.
    PubMed     Abstract available
    
    
    
51. QUINONES N, Fuentes L, Hassan A, Hing AK, et al
    Corrigendum to Society of Family Planning Research Practice Support: Strategies and considerations for addressing race and racism in quantitative family planning studies [Contraception vol 139 (2024) 110534].
    Contraception. 2024 Nov 9:110736. doi: 10.1016/j.contraception.2024.110736.
    PubMed    
    
    
    
52. PARKER AB, Morse JE, Bryant AG
    Permanent Contraception in the childfree population: an exploratory study.
    Contraception. 2024 Nov 8:110746. doi: 10.1016/j.contraception.2024.110746.
    PubMed     Abstract available
    
    
    
53. PAGE ST
    Synthetic Androgens for Male Contraception.
    Contraception. 2024 Nov 6:110735. doi: 10.1016/j.contraception.2024.110735.
    PubMed     Abstract available
    
    
    
54. BERG KA, Gunzler DD, Miller E, Boozer M, et al
    Modeling the impact of decreasing waiting period length for Medicaid sterilization: A multi-site cohort study.
    Contraception. 2024;139:110531.
    PubMed     Abstract available
    
    
    October 2024
55. BITZER J
    Male Contraception - part of gender medicine and reproductive right of men.
    Contraception. 2024 Oct 30:110734. doi: 10.1016/j.contraception.2024.110734.
    PubMed     Abstract available
    
    
    
56. KING T, Caliendo E, Scott E, Diaz GL, et al
    Suspected Hepatotoxicity from Etonogestrel Contraceptive Implant: A Rare Case Report.
    Contraception. 2024 Oct 17:110728. doi: 10.1016/j.contraception.2024.110728.
    PubMed     Abstract available
    
    
    
57. GALLO MF, Schumacher FL, Lawley M, Keim SA, et al
    Potential effect of immediate postpartum use of injectable contraception on lactogenesis.
    Contraception. 2024 Oct 16:110726. doi: 10.1016/j.contraception.2024.110726.
    PubMed     Abstract available
    
    
    
58. ZWAYNE N, Ebersole A, Morse J, Lyman E, et al
    Society of Family Planning Committee statement: Contraception and body weight.
    Contraception. 2024 Oct 11:110725. doi: 10.1016/j.contraception.2024.110725.
    PubMed     Abstract available
    
    
    
59. AXINN WG, West BT, Schroeder HM, Lindberg LD, et al
    Pandemic changes in U.S. contraceptive use: National survey estimates reveal significant differences by demographic subgroups.
    Contraception. 2024 Oct 3:110723. doi: 10.1016/j.contraception.2024.110723.
    PubMed     Abstract available
    
    
    
60. LACY YOUNG M, Mastronardi A, Shelton Z, Maples JM, et al
    Tennessee Medicaid patient immediate postpartum long-acting reversible contraception utilization.
    Contraception. 2024 Oct 1:110721. doi: 10.1016/j.contraception.2024.110721.
    PubMed     Abstract available
    
    
    September 2024
61. OBEDIN-MALIVER J, Snow A, Ragosta S, Fix L, et al
    Contraceptive use among transgender men and gender diverse individuals in the United States: reasons for use, non-use, and methods used for pregnancy prevention.
    Contraception. 2024 Sep 26:110719. doi: 10.1016/j.contraception.2024.110719.
    PubMed     Abstract available
    
    
    
62. MANN ES, Hartheimer J, Bullington BW, Thornton MJ, et al
    Beyond stigma: Clinician bias in contraceptive counseling to sexual and gender minority youth.
    Contraception. 2024 Sep 25:110718. doi: 10.1016/j.contraception.2024.110718.
    PubMed     Abstract available
    
    
    
63. CARMODY MD, Tsevat D, Yates L, Stuart G, et al
    The Association between Socio-Economic Deprivation and Receipt of Long-Acting Reversible Contraception at a Single Clinic Visit.
    Contraception. 2024 Sep 13:110705. doi: 10.1016/j.contraception.2024.110705.
    PubMed     Abstract available
    
    
    
64. ALLISON BA, Bullington BW, Makhijani SA, Arora KS, et al
    Exploring Primary Care Physician Biases in Adolescent Contraceptive Counseling.
    Contraception. 2024 Sep 13:110706. doi: 10.1016/j.contraception.2024.110706.
    PubMed     Abstract available
    
    
    
65. BROWN JA, Ly SH, Thompson JA, Ponizini MD, et al
    Contraceptive Counseling Training Experiences and Behaviors Among Obstetrics and Gynecology Residents in California and Florida.
    Contraception. 2024 Sep 5:110702. doi: 10.1016/j.contraception.2024.110702.
    PubMed     Abstract available
    
    
    
66. CARTER G, Pangasa M, Sexsmith CD, Elliott S, et al
    Selection of LARC methods by emergency contraception clients: A prospective observational study.
    Contraception. 2024 Sep 4:110701. doi: 10.1016/j.contraception.2024.110701.
    PubMed     Abstract available
    
    
    
67. FREEMAN E, Paul R, Dorsey M, Rivera AN, et al
    Demographic differences between patients selecting video or telephone for contraceptive counseling via telehealth.
    Contraception. 2024 Sep 2:110699. doi: 10.1016/j.contraception.2024.110699.
    PubMed     Abstract available
    
    
    
68. BESHAR I, Miller HE, Kruger S, Henkel A, et al
    Mifepristone and misoprostol in California pharmacies after modifications to the Risk Evaluation and Mitigation Strategy Program.
    Contraception. 2024;137:110506.
    PubMed     Abstract available
    
    
    
69. MNUK R, Schrote K, Garg B, Doshi U, et al
    Availability of mifepristone and misoprostol in Oregon pharmacies: A comparison by rural and urban status.
    Contraception. 2024;137:110491.
    PubMed     Abstract available
    
    
    
70. DE OLIVEIRA BR, Alsamman S, Pai M, Mody SK, et al
    "My IUD is expiring": A national U.S. mystery client study regarding use of the LNG 52-mg IUD for pregnancy prevention beyond 5 years after multiple FDA extensions.
    Contraception. 2024;137:110483.
    PubMed     Abstract available
    
    
    August 2024
71. SITRUK-WARE R, Sailer J, Serfaty D, Anderson R, et al
    A new vision for male contraception research and development.
    Contraception. 2024 Aug 28:110695. doi: 10.1016/j.contraception.2024.110695.
    PubMed    
    
    
    
72. PATEL J, Nelson AL, Nguyen BT
    Low to non-existent sperm content of pre-ejaculate in perfect-use contraceptive withdrawal, a pilot study.
    Contraception. 2024 Aug 7:110555. doi: 10.1016/j.contraception.2024.110555.
    PubMed     Abstract available
    
    
    
73. TEIXEIRA DA SILVA JA
    Bibliometric assessment of three retracted papers related to the abortion pill (mifepristone).
    Contraception. 2024;136:110477.
    PubMed    
    
    
    
74. BLECK RR, Danvers AA, Nimbvikar A, Gurney EP, et al
    Medical management of early pregnancy loss with mifepristone and misoprostol in emergency departments compared to a Complex Family Planning office: Implementation of a COVID-19 institutional policy change.
    Contraception. 2024;136:110467.
    PubMed     Abstract available
    
    
    July 2024
75. LAZORWITZ A, Sheeder J, Teal S
    The influence of lifestyle factors on serum etonogestrel concentrations among contraceptive implant users.
    Contraception. 2024 Jul 11:110539. doi: 10.1016/j.contraception.2024.110539.
    PubMed     Abstract available
    
    
    
76. CARROLL AL, Strauss AM, Philipps NM, Kaczmarczik KD, et al
    Efficacy of medication abortion with concurrent initiation of progestin contraceptives: a retrospective cohort study.
    Contraception. 2024 Jul 8:110536. doi: 10.1016/j.contraception.2024.110536.
    PubMed     Abstract available
    
    
    
77. OLIVEIRA JA, Eskandar K, Chagas J, do Nascimento LLO, et al
    Heavy menstrual bleeding in women with inherited bleeding disorders in use of LNG-IUS: A systematic review and single-arm meta-analysis.
    Contraception. 2024;135:110450.
    PubMed     Abstract available
    
    
    
78. DEHLENDORF C, Perry JC, Borrero S, Callegari L, et al
    Meeting people's pregnancy prevention needs: Let's not force people to state an "Intention".
    Contraception. 2024;135:110400.
    PubMed     Abstract available
    
    
    June 2024
79. VISWANATHAN AV, Bullington BW, Berg KA, Miller ES, et al
    Ongoing contraceptive goals of patients who did not achieve desired postpartum permanent contraception prior to hospital discharge.
    Contraception. 2024 Jun 28:110533. doi: 10.1016/j.contraception.2024.110533.
    PubMed     Abstract available
    
    
    
80. CAIRNS-SMITH S, Jaffe HK, Joseph Speidel J
    Contraceptive technology is failing to meet the needs of people in the U.S. because of under-investment in new methods.
    Contraception. 2024 Jun 17:110518. doi: 10.1016/j.contraception.2024.110518.
    PubMed     Abstract available
    
    
    
81. JUM'AH D, Abu-Farha R, Alzoubi KH, Binsaleh AY, et al
    Evaluating Community Pharmacists Awareness, Perception and Roles in Providing Emergency Contraceptives in Jordan.
    Contraception. 2024 Jun 13:110515. doi: 10.1016/j.contraception.2024.110515.
    PubMed     Abstract available
    
    
    
82. RODRIGUEZ MI, Meath THA, Watson K, Daly A, et al
    Decomposition analysis of racial and ethnic differences in receipt of immediate postpartum, long-acting, reversible and permanent contraception.
    Contraception. 2024 Jun 7:110512. doi: 10.1016/j.contraception.2024.110512.
    PubMed     Abstract available
    
    
    
83. UPADHYAY UD, Adkins CE
    Deception by obfuscation: Studnicki et al.'s retracted longitudinal cohort study of emergency room utilization following abortion.
    Contraception. 2024;134:110417.
    PubMed     Abstract available
    
    
    
84. DUTTON C, Mody SK, Nippita S, Dodge LE, et al
    Depot medroxyprogesterone acetate concentrations in patients with and without the use of antiseizure medications.
    Contraception. 2024;134:110418.
    PubMed     Abstract available
    
    
    
85. SHARMA K, Cox S, Romero L, Ekwueme D, et al
    State Variations in Insertion of Long-Acting Reversible Contraception During Delivery Hospitalization.
    Contraception. 2024 Jun 1:110509. doi: 10.1016/j.contraception.2024.110509.
    PubMed     Abstract available
    
    
    May 2024
86. HAGEY JM, Drury KE, Kaplan S, Davidson BA, et al
    Contraceptive Use Following Gestational Trophoblastic Disease: A Systematic Review.
    Contraception. 2024 May 17:110488. doi: 10.1016/j.contraception.2024.110488.
    PubMed     Abstract available
    
    
    
87. TODD CS, Lorenzetti L, Mussa A, Ridgeway K, et al
    Drug-Drug Interactions between Antiretrovirals and Hormonal Contraception: An Updated Systematic Review.
    Contraception. 2024 May 16:110490. doi: 10.1016/j.contraception.2024.110490.
    PubMed     Abstract available
    
    
    
88. MAHR NM, Brown JE
    Contraception and Abortion Attitudes Among Military Medical Students: An Exploratory Study.
    Contraception. 2024 May 15:110489. doi: 10.1016/j.contraception.2024.110489.
    PubMed     Abstract available
    
    
    
89. KENDALL PD, Bresnitz W, Huang J, Sheeder J, et al
    A retrospective analysis of factors associated with deep contraceptive implant removals compared to superficial removals.
    Contraception. 2024 May 14:110486. doi: 10.1016/j.contraception.2024.110486.
    PubMed     Abstract available
    
    
    
90. HEGGIE C, Tong L, Heran A, Bhambhani I, et al
    The role of doulas and community birth workers in abortion and contraception care: An international scoping review.
    Contraception. 2024 May 9:110482. doi: 10.1016/j.contraception.2024.110482.
    PubMed     Abstract available
    
    
    
91. STEVENSON TB, Thapaliya K, Moore V, Mazza D, et al
    Accessibility of oral emergency contraceptives in Australian community pharmacies.
    Contraception. 2024 May 4:110480. doi: 10.1016/j.contraception.2024.110480.
    PubMed     Abstract available
    
    
    
92. SIMS JC, Harris JN, Katzman CL, Wong C, et al
    Confidence in adolescent contraceptive counseling among residents and fellows training at the University of Texas Southwestern in Dallas, Texas.
    Contraception. 2024 May 3:110478. doi: 10.1016/j.contraception.2024.110478.
    PubMed     Abstract available
    
    
    
93. LAURORA I, Henrie B, Guillard H, Bradford R, et al
    Evaluation of adherence to a daily progestin-only pill in a simulated over-the-counter setting.
    Contraception. 2024;133:110388.
    PubMed     Abstract available
    
    
    
94. LA SAPONARA V, Wan S, Nagarkar B, Zwain F, et al
    Understanding the mechanical behavior of intrauterine devices during simulated removal.
    Contraception. 2024;133:110399.
    PubMed     Abstract available
    
    
    
95. DAVIS S, Parthun K, Friend DR
    A nine-month repeat-dose intravaginal ring (Ovaprene) irritation study in sheep.
    Contraception. 2024;133:110387.
    PubMed     Abstract available
    
    
    
96. PERELLO-CAPO J, Estadella-Tarriel J, Gich-Saladich I, Bailon-Queiruga M, et al
    Health-related quality of life and satisfaction associated with 3-year use of a levonorgestrel 13.5 mg intrauterine device vs Nova T copper 380 mm(2) intrauterine device: Results of a phase 4 randomized controlled trial.
    Contraception. 2024;133:110367.
    PubMed     Abstract available
    
    
    April 2024
97. JENSEN JT, Edelman A, Westhoff CL, Schreiber CA, et al
    Use of serum evaluation of contraceptive and ovarian hormones to assess reduced risk of pregnancy among women presenting for emergency contraception in a multicenter clinical trial.
    Contraception. 2024 Apr 24:110475. doi: 10.1016/j.contraception.2024.110475.
    PubMed     Abstract available
    
    
    
98. EDELMAN A, Jensen JT, Brown J, Thomas M, et al
    Emergency contraception for individuals weighing 80kg or greater: a randomized trial of 30 mg ulipristal acetate and 1.5 mg or 3.0 mg levonorgestrel.
    Contraception. 2024 Apr 23:110474. doi: 10.1016/j.contraception.2024.110474.
    PubMed     Abstract available
    
    
    
99. MITCHELL JA, Yao M, Maeda R, Lappen JR, et al
    Permanent and Long-Acting Reversible Contraception volumes at a multi-hospital system in Ohio before and after Dobbs.
    Contraception. 2024 Apr 20:110471. doi: 10.1016/j.contraception.2024.110471.
    PubMed     Abstract available
    
    
    
100. BRANDER C, Risher K, Odwe G, Wado YD, et al
     Individual, partner, and community variables associated with method-specific contraceptive beliefs in urban and rural Kenya.
     Contraception. 2024 Apr 17:110470. doi: 10.1016/j.contraception.2024.110470.
     PubMed     Abstract available
     
     
     
101. CONGDON JL, Vittinghoff E, Dehlendorf C
     Comparison of a Person-Centered Pregnancy Prevention Question and One Key Question(R) to Assess Postpartum Contraceptive Needs.
     Contraception. 2024 Apr 16:110465. doi: 10.1016/j.contraception.2024.110465.
     PubMed     Abstract available
     
     
     
102. MASTERS GA, Julce C, Carroll S, Person SD, et al
     Association of Perinatal Depression and Postpartum Contraception Intent, Choice, and Actual Use.
     Contraception. 2024 Apr 5:110447. doi: 10.1016/j.contraception.2024.110447.
     PubMed     Abstract available
     
     
     
103. LAZARIS E, Sanders JN, Carter G, Olsen J, et al
     Contraceptive uptake among gender-expansive individuals in the HER Salt Lake Contraceptive Initiative.
     Contraception. 2024 Apr 5:110446. doi: 10.1016/j.contraception.2024.110446.
     PubMed     Abstract available
     
     
     
104. HAEDER SF, Marthey D, Skinner D
     US public opinion about reproductive health care in school-based health centers.
     Contraception. 2024;132:110374.
     PubMed     Abstract available
     
     
     
105. LAMBERT SJ, Lunde B, Porsch L, Stoffels G, et al
     Adjuvant misoprostol or mifepristone for cervical preparation with osmotic dilators before dilation and evacuation.
     Contraception. 2024;132:110364.
     PubMed     Abstract available
     
     
     
106. FREE LL, Brown BP, Matteson KA, Cronin B, et al
     Longitudinal impact of a residency-based postplacental levonorgestrel intrauterine device insertion program: Expulsion rates in years 1, 2, and 3.
     Contraception. 2024;132:110362.
     PubMed     Abstract available
     
     
     
107. SIUM AF, Teklu H, Reeves M, Tolu LB, et al
     One-day versus two-day mifepristone-misoprostol interval prior to initiation of misoprostol during late second trimester medication abortion: A cohort study.
     Contraception. 2024;132:110356.
     PubMed     Abstract available
     
     
     March 2024
108. LANDS M, Dyer RL, Seymour JW
     Corrigendum to: "Sampling strategies among studies of barriers to abortion in the United States: A scoping review of abortion access research'' [Contraception 2024; 131:110342].
     Contraception. 2024 Mar 29:110435. doi: 10.1016/j.contraception.2024.110435.
     PubMed    
     
     
     
109. NGUYEN BT
     The Demand for Male Contraception: estimating the potential market for users of novel male contraceptive methods using United States National Survey of Family Growth data.
     Contraception. 2024 Mar 28:110438. doi: 10.1016/j.contraception.2024.110438.
     PubMed     Abstract available
     
     
     
110. MONACO AE, Westhoff CL
     Evaluating virtual visits for contraceptive counseling: an exploratory study using the Person-Centered Contraceptive Counseling (PCCC) scale, a patient-reported outcome measure.
     Contraception. 2024 Mar 27:110443. doi: 10.1016/j.contraception.2024.110443.
     PubMed     Abstract available
     
     
     
111. CLURE C, Sheeder J, Lazorwitz A
     Pilot study of a novel, alternative subdermal scapular insertion site for the etonogestrel contraceptive implant.
     Contraception. 2024 Mar 27:110442. doi: 10.1016/j.contraception.2024.110442.
     PubMed     Abstract available
     
     
     
112. STEWART A, Lisa Romero, Kortsmit K, Hurst S, et al
     Long-Acting Reversible Contraception Use and Unmet Desire among Patients After the Zika Contraception Access Network Program in Puerto Rico.
     Contraception. 2024 Mar 27:110441. doi: 10.1016/j.contraception.2024.110441.
     PubMed     Abstract available
     
     
     
113. MAUCK C, Thurman A, Jensen JT, Schreiber CA, et al
     Safety Testing of Ovaprene: an Investigational Non-Hormonal Monthly Vaginal Contraceptive.
     Contraception. 2024 Mar 27:110440. doi: 10.1016/j.contraception.2024.110440.
     PubMed     Abstract available
     
     
     
114. HUMPHREYS A, Stevenson AJ, Yeatman S
     Changes in Contraceptive Method Mix Following the Colorado Family Planning Initiative.
     Contraception. 2024 Mar 21:110422. doi: 10.1016/j.contraception.2024.110422.
     PubMed     Abstract available
     
     
     
115. YARGER J, Hopkins K, Elmes S, Rossetto I, et al
     Use of telemedicine to obtain contraception among young adults: Inequities by health insurance.
     Contraception. 2024 Mar 9:110419. doi: 10.1016/j.contraception.2024.110419.
     PubMed     Abstract available
     
     
     
116. WAGNER B, Cleland K
     Increases in Retail Sales of Over-the-counter Levonorgestrel Emergency Contraception in the United States, 2016-2022.
     Contraception. 2024 Mar 8:110420. doi: 10.1016/j.contraception.2024.110420.
     PubMed     Abstract available
     
     
     
117. COMFORT AB, Alvarez A, Goodman S, Upadhyay U, et al
     Provision of DMPA-SC for self-administration in different practice settings during the COVID-19 pandemic: Data from providers across the United States.
     Contraception. 2024;131:110360.
     PubMed     Abstract available
     
     
     
118. SANDOVAL S, Rafie S, Kully G, Mody S, et al
     Pharmacist provision of medication abortion: A pilot study.
     Contraception. 2024;131:110346.
     PubMed     Abstract available
     
     
     
119. JOHNSON DM, Ramaswamy S, Gomperts R
     Experiences with misoprostol-only used for self-managed abortion and acquired from an online or retail pharmacy in the United States.
     Contraception. 2024;131:110345.
     PubMed     Abstract available
     
     
     
120. BHARADWA S, Fulcher I, Fortin J, Pocius KD, et al
     hCG trends after mifepristone and misoprostol for undesired pregnancy of unknown location.
     Contraception. 2024;131:110343.
     PubMed     Abstract available
     
     
     
121. RAYMOND EG, Frye LJ, Tocce K, Gingras S, et al
     Evaluation of a "smart" screening tool for asynchronous assessment of medication abortion eligibility: A pilot study.
     Contraception. 2024;131:110340.
     PubMed     Abstract available
     
     
     February 2024
122. MEURICE ME, Mody SK, Nodora J, Marengo A, et al
     Social determinants of choosing telemedicine for contraceptive care: a retrospective cohort study.
     Contraception. 2024 Feb 29:110414. doi: 10.1016/j.contraception.2024.110414.
     PubMed     Abstract available
     
     
     
123. TSEVAT D, Mercier R, Bernheimer C, Lin S, et al
     Amenorrhea in Adolescents Using the Etonogestrel Contraceptive Implant.
     Contraception. 2024 Feb 22:110413. doi: 10.1016/j.contraception.2024.110413.
     PubMed     Abstract available
     
     
     
124. SOBER S, Bradford R, Henrie B, Pradeau S, et al
     Evaluation of consumer self-selection of a proposed over-the-counter, progestin-only daily oral contraceptive.
     Contraception. 2024 Feb 21:110401. doi: 10.1016/j.contraception.2024.110401.
     PubMed     Abstract available
     
     
     
125. SAKTHIVEL M, Wolff H, Monast K, McHugh A, et al
     Mifepristone implementation in primary care: Clinician and staff insights from a pilot learning collaborative.
     Contraception. 2024;130:110280.
     PubMed     Abstract available
     
     
     January 2024
126. PAIK J, Haenisch M, Kim A, Snyder JM, et al
     Corrigendum to: "Return to fertility, toxicology, and transgenerational impact of treatment with WIN 18,446, a potential male contraceptive, in mice" [Contraception. 129 (2024) 110306].
     Contraception. 2024 Jan 22:110371. doi: 10.1016/j.contraception.2024.110371.
     PubMed    
     
     
     
127. BOEHNKE T, Franke C, Bauerfeind A, Heinemann K, et al
     Systematic analysis of combined oral contraceptive prescription patterns in psychotropic drug users across 12 European countries.
     Contraception. 2024 Jan 20:110375. doi: 10.1016/j.contraception.2024.110375.
     PubMed     Abstract available
     
     
     
128. FATIMA LL, Alonso Llamazares MJ, Mausbach Reisen H, Parra Ribes I, et al
     Impact of the hands-on Clinical Training Program (CTP) for subdermic implant on contraceptive counselling and users' choice in Spain: A six months follow up study.
     Contraception. 2024 Jan 16:110372. doi: 10.1016/j.contraception.2024.110372.
     PubMed     Abstract available
     
     
     
129. MAUCK C, Thurman A, Jensen JT, Schreiber CA, et al
     Successful Postcoital Testing of Ovaprene: an Investigational Non-Hormonal Monthly Vaginal Contraceptive.
     Contraception. 2024 Jan 15:110373. doi: 10.1016/j.contraception.2024.110373.
     PubMed     Abstract available
     
     
     
130. GAWRON LM, Kaiser JE, Gero A, Sanders JN, et al
     Pharmacodynamic evaluation of the etonogestrel contraceptive implant initiated midcycle with and without ulipristal acetate: an exploratory study.
     Contraception. 2024 Jan 15:110370. doi: 10.1016/j.contraception.2024.110370.
     PubMed     Abstract available
     
     
     
131. CARRANCO S, Bohac S, Casey S, Sangi-Haghpeykar H, et al
     A Survey Of Contraceptive Method Use Among Patients With Delayed Permanent Contraception Due To The COVID-19 Pandemic.
     Contraception. 2024 Jan 13:110369. doi: 10.1016/j.contraception.2024.110369.
     PubMed     Abstract available
     
     
     
132. HALE N, Dehlendorf C, Smith MG, Stapleton J, et al
     Contraceptive Counseling, Method Satisfaction, and Planned Method Continuation among Women in the U.S. Southeast.
     Contraception. 2024 Jan 10:110365. doi: 10.1016/j.contraception.2024.110365.
     PubMed     Abstract available
     
     
     
133. LAPORTE M, Marcelino AC, Pereira PDC, Espejo-Arce X, et al
     Uptake, discontinuation, and continuation rate of long-acting contraceptive methods (LARC) when offered at no cost in Campinas, Brazil.
     Contraception. 2024 Jan 7:110363. doi: 10.1016/j.contraception.2024.110363.
     PubMed     Abstract available
     
     
     
134. SOKOL NA, Sawadogo N, Bullington BW, Tumlinson K, et al
     Perceptions of access to long-acting reversible contraception removal among women in Burkina Faso.
     Contraception. 2024;129:110302.
     PubMed     Abstract available
     
     
     
135. GEDESTAD I, Munnangi M, Chamberlain A, Shabaik S, et al
     Five years later: Can women in Los Angeles County, California, get adequate pill supplies?
     Contraception. 2024;129:110294.
     PubMed     Abstract available
     
     
     December 2023
136. YI H, Stamm CA, Wright G, Mondie WS, et al
     Emergency contraception in a historic southern city: mystery caller study in Birmingham, Alabama.
     Contraception. 2023 Dec 29:110361. doi: 10.1016/j.contraception.2023.110361.
     PubMed     Abstract available
     
     
     
137. BORGES ALV, Lay AAR, Duarte LS, Chofakian CBDN, et al
     Changes in contraceptive use during the second COVID-19 lockdown in Brazil: a web-based survey.
     Contraception. 2023 Dec 28:110359. doi: 10.1016/j.contraception.2023.110359.
     PubMed     Abstract available
     
     
     
138. SINTHUCHAI N, Tapanwong N, Apirakviriya C, Pohthipornthawat N, et al
     The effect of a single-dose of a combination injectable contraceptive for treatment of bothersome uterine bleeding in contraceptive implant(s) users; a randomized double-blind placebo-controlled trial.
     Contraception. 2023 Dec 14:110354. doi: 10.1016/j.contraception.2023.110354.
     PubMed     Abstract available
     
     
     
139. DOTY N, Beckley E, Garg B, Maristany S, et al
     Changes in hair cortisol concentration in intrauterine device initiators: A prospective cohort study.
     Contraception. 2023;128:110142.
     PubMed     Abstract available
     
     
     
140. CHATILLON A, Vizcarra E, Kumar B, Dickman SL, et al
     Access to care following Planned Parenthood's termination from Texas' Medicaid network: A qualitative study.
     Contraception. 2023;128:110141.
     PubMed     Abstract available
     
     
     
141. SPIELVOGEL R, Stephens RB, Clark R, Guillen M, et al
     Providing family planning counseling services for women with chronic medical conditions in an inpatient setting: A randomized feasibility trial.
     Contraception. 2023;128:110133.
     PubMed     Abstract available
     
     
     November 2023
142. STOWERS P, Heck R, Csiszar K, Kaneshiro B, et al
     Corrigendum to "Just world beliefs and community-level abortion stigma: An exploratory survey" [Contraception 2023;122:109979].
     Contraception. 2023 Nov 27:110341. doi: 10.1016/j.contraception.2023.110341.
     PubMed    
     
     
     
143. GAWRON LM, Sexsmith CD, Carter G, Kaiser JE, et al
     Efficacy of oral levonorgestrel emergency contraception with same day etonogestrel contraceptive implant: A prospective observational study.
     Contraception. 2023 Nov 24:110344. doi: 10.1016/j.contraception.2023.110344.
     PubMed     Abstract available
     
     
     
144. SZNAJDER K, Thaler K, Perin J, Burke AE, et al
     Development and evaluation of measures to assess self-determination in peripartum contraceptive decision-making.
     Contraception. 2023 Nov 16:110329. doi: 10.1016/j.contraception.2023.110329.
     PubMed     Abstract available
     
     
     
145. PERELLO-CAPO J, Estadella-Tarriel J, Gich-Saladich I, Bailon-Queiruga M, et al
     Bleeding profile and safety of a levonorgestrel 13.5 mg intrauterine device versus Nova T copper 380 mm(2) intrauterine device: Results of a 3-year, single-center, randomized phase 4 study.
     Contraception. 2023;127:110127.
     PubMed     Abstract available
     
     
     
146. RAYMOND EG, Weaver MA, Shochet T
     Effectiveness and safety of misoprostol-only for first-trimester medication abortion: An updated systematic review and meta-analysis.
     Contraception. 2023;127:110132.
     PubMed     Abstract available
     
     
     October 2023
147. JONAS K, Bergh K, Duby Z, Mangoale K, et al
     Using prevention cascades to investigate coverage of contraception services among young women enrolled in a large-scale combination HIV prevention programme in South Africa.
     Contraception. 2023 Oct 18:110307. doi: 10.1016/j.contraception.2023.110307.
     PubMed     Abstract available
     
     
     
148. STANCZYK FZ, Winer SA, Foidart JM, Archer DF, et al
     Comparison of Estrogenic Components Used for Hormonal Contraception.
     Contraception. 2023 Oct 18:110310. doi: 10.1016/j.contraception.2023.110310.
     PubMed     Abstract available
     
     
     
149. LINDER M, Schoendorf J, Pisa F, Schulze-Rath R, et al
     Characteristics and hormonal contraception use patterns of levonorgestrel 13.5 mg intrauterine device users in Sweden 2014-2016.
     Contraception. 2023 Oct 14:110309. doi: 10.1016/j.contraception.2023.110309.
     PubMed     Abstract available
     
     
     
150. PAIK J, Haenisch M, Kim A, Snyder JM, et al
     Return to Fertility, Toxicology, and Transgenerational Impact of Treatment with WIN 18,446, a Potential Male Contraceptive, in Mice.
     Contraception. 2023 Oct 7:110306. doi: 10.1016/j.contraception.2023.110306.
     PubMed     Abstract available
     
     
     
151. WINGO E, Dehlendorf C
     Lack of pregnancy intention or interest in pregnancy prevention now? How best to screen for desire for contraceptive care.
     Contraception. 2023 Oct 6:110303. doi: 10.1016/j.contraception.2023.110303.
     PubMed     Abstract available
     
     
     
152. WOLFF H, McHugh A, Qadir S, Lassar M, et al
     Reproductive care in community health centers: Multi-method evaluation of the Illinois Contraceptive Access Now (ICAN!) demonstration program.
     Contraception. 2023 Oct 6:110305. doi: 10.1016/j.contraception.2023.110305.
     PubMed     Abstract available
     
     
     
153. SHIM JY, Ryan ME, Milliren CE, Maslyanskaya S, et al
     Continuation Rates of Hormonal Intrauterine Devices in Adolescents and Young Adults when placed for Contraceptive and Non-Contraceptive Indications.
     Contraception. 2023 Oct 6:110304. doi: 10.1016/j.contraception.2023.110304.
     PubMed     Abstract available
     
     
     
154. COSTANZO MA, Magnuson KA, Gennetian LA, Halpern-Meekin S, et al
     Contraception Use and Satisfaction Among Mothers with Low-Income: Evidence from the Baby's First Years Study.
     Contraception. 2023 Oct 6:110297. doi: 10.1016/j.contraception.2023.110297.
     PubMed     Abstract available
     
     
     
155. JANTTI C, Toffol E, Partonen T, Haukka J, et al
     Contraceptive plans and purchase after an induced abortion: a nationwide register study from Finland.
     Contraception. 2023 Oct 5:110299. doi: 10.1016/j.contraception.2023.110299.
     PubMed     Abstract available
     
     
     
156. DIAMOND B, Sheeder J, Lazorwitz A
     An exploratory study on the possible association of serum etonogestrel concentrations with mood concerns and symptoms among contraceptive implant users.
     Contraception. 2023 Oct 4:110298. doi: 10.1016/j.contraception.2023.110298.
     PubMed     Abstract available
     
     
     
157. STODDARD RE, Pelletier A, Sundquist EN, Haas-Kogan ME, et al
     Popular Contraception Videos on TikTok: An Assessment of Content Topics.
     Contraception. 2023 Oct 4:110300. doi: 10.1016/j.contraception.2023.110300.
     PubMed     Abstract available
     
     
     
158. BAKER CC, Wu BT, Han G, Flynn AN, et al
     Early pregnancy loss medical management in clinical practice.
     Contraception. 2023;126:110134.
     PubMed     Abstract available
     
     
     
159. JUAREZ-CHAVEZ E, Villalobos Ruiz JH, Carrasco Navarro RM, Guerrero Vasquez R, et al
     Exploring the prevalence of abortion and its characteristics in Peru.
     Contraception. 2023;126:110115.
     PubMed     Abstract available
     
     
     
160. NEILL S, Hoe E, Fortin J, Goldberg AB, et al
     Management of early pregnancy loss among obstetrician-gynecologists in Massachusetts and barriers to mifepristone use.
     Contraception. 2023;126:110108.
     PubMed     Abstract available
     
     
     
161. RAYMOND EG, Weaver MA, Shochet T, Grant M, et al
     Clinical outcomes of medication abortion using misoprostol-only: A retrospective chart review at an abortion provider organization in the United States.
     Contraception. 2023;126:110109.
     PubMed     Abstract available
     
     
     September 2023
162. JONAS K, Lombard C, Chirinda W, Govindasamy D, et al
     Corrigendum to "Participation in an HIV prevention intervention and access to and use of contraceptives among young women: A cross-sectional analysis in six South African districts" [Contraception 116 (2022) 51-58].
     Contraception. 2023 Sep 22:110281. doi: 10.1016/j.contraception.2023.110281.
     PubMed    
     
     
     
163. ROBERTS CM, Smalley JM, Adelman WP, Weir LF, et al
     Brief Report: Influence of mandatory contraceptive education emphasizing long-acting reversible methods on continuation rates among military recruits.
     Contraception. 2023 Sep 20:110295. doi: 10.1016/j.contraception.2023.110295.
     PubMed     Abstract available
     
     
     
164. GAGE AJ, Akilimali PZ, Wood FE, Gay R, et al
     Evaluation of the effect of the Momentum project on family planning outcomes among first-time mothers aged 15-24 years in Kinshasa, DRC.
     Contraception. 2023;125:110088.
     PubMed     Abstract available
     
     
     
165. DE LOTT LB, Moniz MH, Niziol LM, Khanna S, et al
     Levonorgestrel intrauterine device use and incident idiopathic intracranial hypertension among commercially insured women.
     Contraception. 2023;125:110089.
     PubMed     Abstract available
     
     
     
166. SIUM AF, Shimeles T, Gudu W
     The effect of induced fetal demise on induction to expulsion interval during later medication abortion: A retrospective cohort.
     Contraception. 2023;125:110092.
     PubMed     Abstract available
     
     
     
167. DICKINSON JE, Doherty DA
     Maternal complications associated with second trimester medical abortion using mifepristone priming and subsequent misoprostol.
     Contraception. 2023;125:110080.
     PubMed     Abstract available
     
     
     August 2023
168. JONES A, Whitesell C, Tadikonda A, Perry MF, et al
     "I feel like it gives me what I need to know": A qualitative study on adolescent perceptions of two contraceptive decision aids.
     Contraception. 2023 Aug 31:110277. doi: 10.1016/j.contraception.2023.110277.
     PubMed     Abstract available
     
     
     
169. XUAN NGUYEN TT, Quynh Nguyen TT, Huong Le L, Dinh DX, et al
     Knowledge, attitudes, and practices towards emergency contraceptive pills among community pharmacists and pharmacy customers: a cross-sectional study in urban Vietnam.
     Contraception. 2023 Aug 30:110275. doi: 10.1016/j.contraception.2023.110275.
     PubMed     Abstract available
     
     
     
170. THOMAS K, Malhotra T, Ngendahimana D, Gibson KS, et al
     Postpartum contraceptive choice and fulfillment in patients with opioid use disorder.
     Contraception. 2023 Aug 24:110267. doi: 10.1016/j.contraception.2023.110267.
     PubMed     Abstract available
     
     
     
171. MAUCK CK, Dart C, Thurman A, Creinin MD, et al
     Contraceptive efficacy should primarily be measured using life table pregnancy rates.
     Contraception. 2023 Aug 8:110140. doi: 10.1016/j.contraception.2023.110140.
     PubMed    
     
     
     
172. QASBA NT, Wallace KF, Yu V, Capoccia KL, et al
     Online survey of consumer awareness and perceptions of a Massachusetts law for 12-month-supply of contraception.
     Contraception. 2023 Aug 4:110138. doi: 10.1016/j.contraception.2023.110138.
     PubMed     Abstract available
     
     
     
173. CREININ MD, Angulo A, Colli E, Archer DF, et al
     The efficacy, safety and tolerability of an estrogen-free oral contraceptive drospirenone 4 mg (24/4-day regimen) in obese users.
     Contraception. 2023 Aug 4:110136. doi: 10.1016/j.contraception.2023.110136.
     PubMed     Abstract available
     
     
     
174. ANGER HA, Raymond EG
     Implications of using home urine pregnancy tests versus facility-based tests for assessment of outcome following medication abortion provided via telemedicine.
     Contraception. 2023;124:110055.
     PubMed     Abstract available
     
     
     July 2023
175. ABERNATHEY L, Ryan ME, Golub S, Ahrens K, et al
     Long-acting Reversible Contraception in Gender-Diverse Adolescents and Young Adults: Outcomes from a Multisite Collaborative.
     Contraception. 2023 Jul 28:110131. doi: 10.1016/j.contraception.2023.110131.
     PubMed     Abstract available
     
     
     
176. JENSEN JT, Waites BT, Boniface ER, McCrimmon S, et al
     Development and validation of an expanded panel of progestins using liquid chromatography-tandem triple quadrupole mass spectrometry (LC-MS/MS) to monitor protocol compliance in hormonal contraceptive pharmacokinetic/pharmacodynamic studies.
     Contraception. 2023 Jul 25:110130. doi: 10.1016/j.contraception.2023.110130.
     PubMed     Abstract available
     
     
     
177. FREEMAN E, Paul R, Dorsey M, Madden T, et al
     Comparison of interpersonal quality of contraceptive counseling delivered via telehealth versus in-person.
     Contraception. 2023 Jul 25:110129. doi: 10.1016/j.contraception.2023.110129.
     PubMed     Abstract available
     
     
     
178. RUELLE Y, Haghighi S, Guillot O
     Effects of a short training workshop on the insertion/removal of intrauterine devices and contraceptive implants by general practice residents and their supervisors.
     Contraception. 2023 Jul 17:110117. doi: 10.1016/j.contraception.2023.110117.
     PubMed     Abstract available
     
     
     
179. GUTMAN S, Connor H, Mumford SL, Gilmore E, et al
     Feasibility and acceptability of virtual group contraceptive counseling prior to abortion care.
     Contraception. 2023 Jul 17:110114. doi: 10.1016/j.contraception.2023.110114.
     PubMed     Abstract available
     
     
     
180. ROSENBERG JD, Raymond E, Shochet T
     Corrigendum to "An examination of loss to follow-up and potential bias in outcome ascertainment in a study of direct-to-patient telemedicine abortion in the United States" Contraception, Volume 122, 109996 (June 2023).
     Contraception. 2023 Jul 5:110098. doi: 10.1016/j.contraception.2023.110098.
     PubMed    
     
     
     
181. RODRIGUEZ MI, Acevedo AM, Renfro S, Tasset J, et al
     Association of intrapartum severe maternal morbidity with receipt of postpartum contraception among Medicaid recipients.
     Contraception. 2023 Jul 4:110110. doi: 10.1016/j.contraception.2023.110110.
     PubMed     Abstract available
     
     
     
182. FIASTRO AE, Young E, Jacob-Files E, Ruben MR, et al
     Advance provision of medication for induced abortion: A qualitative study of patient perspectives.
     Contraception. 2023;123:110050.
     PubMed     Abstract available
     
     
     
183. DICENZO N, Shah N, Glassman D, Singla A, et al
     Active COVID-19 infection as a barrier to postpartum tubal ligation.
     Contraception. 2023;123:110051.
     PubMed     Abstract available
     
     
     
184. SMITH TJ, Urdanigo TK, Shroff N, Rubin SE, et al
     Patient's experience and satisfaction with self-administered subcutaneous depot medroxyprogesterone acetate use during the first year of COVID-19.
     Contraception. 2023;123:110008.
     PubMed     Abstract available
     
     
     
185. BOEHNKE T, Eggebrecht L, Viet M, Heinemann K, et al
     How did regional lockdowns during the COVID-19 pandemic affect recruitment into a large multinational cohort study of intrauterine device users?
     Contraception. 2023;123:110003.
     PubMed     Abstract available
     
     
     
186. YARON M, Legardeur H, Barcellini B, Akhoundova F, et al
     Safety and efficacy of a suction cervical stabilizer for intrauterine contraceptive device insertion: Results from a randomized, controlled study.
     Contraception. 2023;123:110004.
     PubMed     Abstract available
     
     
     June 2023
187. SILEO KM, Muhumuza C, Wanyenze RK, Kershaw TS, et al
     A pilot quasi-experimental controlled trial of a community-based, multi-level family planning intervention for couples in rural Uganda: evidence of feasibility, acceptability, and effect on contraceptive uptake among those with an unmet need for famil
     Contraception. 2023 Jun 22:110096. doi: 10.1016/j.contraception.2023.110096.
     PubMed     Abstract available
     
     
     
188. BREWER M, Clifton T
     Religious affiliation and women's receipt of person-centered contraceptive care: Findings from the National Survey of Family Growth, 2017-2019.
     Contraception. 2023 Jun 19:110097. doi: 10.1016/j.contraception.2023.110097.
     PubMed     Abstract available
     
     
     
189. LAZORWITZ A, Sheeder J
     Validation of 24-hour trough concentration as a proxy for intensive pharmacokinetic measurements for a combined oral contraceptive pill containing desogestrel.
     Contraception. 2023 Jun 16:110093. doi: 10.1016/j.contraception.2023.110093.
     PubMed     Abstract available
     
     
     
190. KUS LH, Paul R, Nigaglioni Rivera A, Zeal C, et al
     Improvement in contraceptive knowledge after using an online educational resource.
     Contraception. 2023 Jun 16:110095. doi: 10.1016/j.contraception.2023.110095.
     PubMed     Abstract available
     
     
     
191. OSTERBUR BADHEY ML, Li S, Alimena S, Johnson NR, et al
     Allergic and infectious complications of Etonogestrel implant placements: A case series.
     Contraception. 2023;122:109994.
     PubMed     Abstract available
     
     
     
192. ANJOS FCQS, Marcelino AC, Espejo-Arce X, Pereira PDC, et al
     Pain and ease of insertion of three different intrauterine devices in Brazilian adolescents: A participant-blinded randomized trial.
     Contraception. 2023;122:109997.
     PubMed     Abstract available
     
     
     
193. WOLLUM A, Zuniga C, Blanchard K, Teal S, et al
     A commentary on progestin-only pills and the "three-hour window" guidelines: Timing of ingestion and mechanisms of action.
     Contraception. 2023;122:109978.
     PubMed     Abstract available
     
     
     
194. CIRRINCIONE LR, Nakalema S, Chappell CA, Byakika-Kibwika P, et al
     Effect of double-dose levonorgestrel subdermal implant in women taking efavirenz-based antiretroviral therapy: The DoubLNG pharmacokinetic study.
     Contraception. 2023;122:109975.
     PubMed     Abstract available
     
     
     May 2023
195. MANG A, Jetelina KK, Mcneely C, Durante JC, et al
     Characteristics of parents who think intrauterine devices or contraceptive implants are "best" for their daughter: An exploratory analysis.
     Contraception. 2023 May 30:110084. doi: 10.1016/j.contraception.2023.110084.
     PubMed     Abstract available
     
     
     
196. LOH M, Niu L, Arden M, Burk RD, et al
     Long-acting reversible contraception and condom use: A cohort study of female adolescents and young adults in New York City.
     Contraception. 2023 May 30:110081. doi: 10.1016/j.contraception.2023.110081.
     PubMed     Abstract available
     
     
     
197. SULGER E, Jung C, Nippita S
     Avoiding unintended pregnancy during transition from copper intrauterine device to etonogestrel contraceptive implant: A case report.
     Contraception. 2023 May 29:110085. doi: 10.1016/j.contraception.2023.110085.
     PubMed     Abstract available
     
     
     
198. SONALKAR S, Kete C, McAllister A, Afreen R, et al
     Perceptions of HIV risk screening strategies among patients seeking abortion, contraception, and pregnancy loss management in the United States.
     Contraception. 2023 May 18:110063. doi: 10.1016/j.contraception.2023.110063.
     PubMed     Abstract available
     
     
     
199. AMORY JK, Blithe DL, Ware RS, Swerdloff RS, et al
     Design of an International Male Contraceptive Efficacy Trial Using a Self-Administered Daily Transdermal Gel Containing Testosterone and Segesterone Acetate (Nestorone(R)).
     Contraception. 2023 May 18:110064. doi: 10.1016/j.contraception.2023.110064.
     PubMed     Abstract available
     
     
     
200. SHAW JG, Goldthwaite LM, Maric I, Shaw KA, et al
     Postpartum long-acting reversible contraception among privately insured: national analysis 2007-2016, by term and preterm birth.
     Contraception. 2023 May 18:110065. doi: 10.1016/j.contraception.2023.110065.
     PubMed     Abstract available
     
     
     
201. FOSTER AM, Darney BG, Nguyen BT, Russo J, et al
     Advancing diversity, equity, inclusion, and anti-racism in Contraception: A statement of commitment from the Editorial Board.
     Contraception. 2023 May 17:110066. doi: 10.1016/j.contraception.2023.110066.
     PubMed    
     
     
     
202. ERMIAS Y, Averbach SH, Dey AK, Gebrehanna E, et al
     The Association Between Quality of Contraceptive Counseling and Selection of Contraceptive Method Post-counseling Among Women in Ethiopia.
     Contraception. 2023 May 11:110060. doi: 10.1016/j.contraception.2023.110060.
     PubMed     Abstract available
     
     
     
203. RAYMOND EG, Mark A, Grossman D, Beasley A, et al
     Medication abortion with misoprostol-only: A sample protocol.
     Contraception. 2023;121:109998.
     PubMed    
     
     
     
204. KOENIG LR, Raymond EG, Gold M, Boraas CM, et al
     Mailing abortion pills does not delay care: A cohort study comparing mailed to in-person dispensing of abortion medications in the United States.
     Contraception. 2023;121:109962.
     PubMed     Abstract available
     
     
     April 2023
205. RODRIGUEZ MI, Skye M, Schrote K, Linz R, et al
     Contraceptive services in Oregon's state-funded network during the COVID-19 pandemic.
     Contraception. 2023 Apr 21:110054. doi: 10.1016/j.contraception.2023.110054.
     PubMed     Abstract available
     
     
     
206. JONES EJ, Dehlendorf C, Kriz R, Grzeniewski M, et al
     Using the Person-Centered Contraceptive Counseling (PCCC) Measure for Quality Improvement.
     Contraception. 2023 Apr 12:110040. doi: 10.1016/j.contraception.2023.110040.
     PubMed     Abstract available
     
     
     
207. SHEA M, Decker E, LeRoy L, Winter M, et al
     Testing the Validity and Reliability of the Person-Centered Contraceptive Care (PCCC) Performance Measure in a Real-World Contraceptive Access Program.
     Contraception. 2023 Apr 6:110039. doi: 10.1016/j.contraception.2023.110039.
     PubMed     Abstract available
     
     
     
208. PAI M, Rigler N, de Oliveira BR, Mody SK, et al
     "My implant is expiring": A national U.S. mystery shopper study regarding extended use of the contraceptive implant.
     Contraception. 2023 Apr 3:110038. doi: 10.1016/j.contraception.2023.110038.
     PubMed     Abstract available
     
     
     
209. SHADY NW, Farouk HA, Sallam HF
     A randomized double blinded clinical trial to explore the clinical outcomes of vaginal isonicotinic acid hydrazide (INH) administration six hours prior to T380A intrauterine device insertion in persons delivered only by cesarean delivery. Contraceptio
     Contraception. 2023;120:109973.
     PubMed    
     
     
     
210. QUINN DA, Sileanu FE, Borrero S, Callegari LS, et al
     Reproductive health services: A missed opportunity in VA primary care?
     Contraception. 2023;120:109957.
     PubMed     Abstract available
     
     
     
211. GILBERT AL, Gelfand D, Fortin J, Roncari D, et al
     At-home urine pregnancy test assessment after mifepristone and misoprostol for undesired pregnancy of unknown location.
     Contraception. 2023;120:109955.
     PubMed     Abstract available
     
     
     
212. JENSEN JT, Reinecke I, Post TM, Lukkari-Lax E, et al
     Extended use of levonorgestrel-releasing intrauterine system (LNG-IUS) 52 mg: A population pharmacokinetic approach to estimate in vivo levonorgestrel release rates and systemic exposure including comparison with two other LNG-IUSs.
     Contraception. 2023;120:109954.
     PubMed     Abstract available
     
     
     
213. REED S, Minh TD, Lange JA, Koro C, et al
     Pregnancy and pregnancy outcomes in a prospective cohort study: Final results from the Nexplanon Observational Risk Assessment Study (NORA).
     Contraception. 2023;120:109920.
     PubMed     Abstract available
     
     
     
214. SHOCHET T, Turok D, Frye LJ, Sexsmith CD, et al
     Single dose letrozole and misoprostol for termination of pregnancy through 63 days' gestation: A pilot study.
     Contraception. 2023;120:109924.
     PubMed     Abstract available
     
     
     March 2023
215. LAZORWITZ A, Sheeder J, Teal S
     The effect of rifampin on serum etonogestrel concentrations and biomarkers of ovulation among contraceptive implant users: a pharmacokinetic and pharmacodynamic study.
     Contraception. 2023 Mar 28:110035. doi: 10.1016/j.contraception.2023.110035.
     PubMed     Abstract available
     
     
     
216. DEHLENDORF C, Vittinghoff E, Silverstein I, Fox E, et al
     Prioritizing Patient Experience: Validation of the Person-Centered Contraceptive Counseling Measure as a Performance Measure.
     Contraception. 2023 Mar 17:110010. doi: 10.1016/j.contraception.2023.110010.
     PubMed     Abstract available
     
     
     
217. STUART GS, Yates L, Crump J, Allison BA, et al
     Single-visit insertion of long-acting reversible contraception in a single health system.
     Contraception. 2023 Mar 15:110009. doi: 10.1016/j.contraception.2023.110009.
     PubMed     Abstract available
     
     
     
218. NGUYEN BT, Jacobsohn TL
     Men's willingness to use novel male contraception is linked to gender-equitable attitudes: results from an exploratory online survey.
     Contraception. 2023 Mar 14:110001. doi: 10.1016/j.contraception.2023.110001.
     PubMed     Abstract available
     
     
     
219. WILKINSON TA, Meredith AH, Katz AJ, Meagher CG, et al
     Assessment of Adolescent Decision-Making Capacity for Pharmacy Access to Hormonal Contraception.
     Contraception. 2023 Mar 11:110002. doi: 10.1016/j.contraception.2023.110002.
     PubMed     Abstract available
     
     
     
220. MERZ AA, Kerns JL, Logan R, Gutierrez S, et al
     Contraceptive care in the United States during the COVID-19 pandemic: a social media survey study of contraceptive access, telehealth use and telehealth quality.
     Contraception. 2023 Mar 3:110000. doi: 10.1016/j.contraception.2023.110000.
     PubMed     Abstract available
     
     
     February 2023
221. BURY F, Iguyovwe V, Trivett M, Baraitser P, et al
     Patterns of use of emergency and oral contraceptives from an online service in the UK during the COVID-19 pandemic: a quantitative study of routinely collected data.
     Contraception. 2023 Feb 25:109992. doi: 10.1016/j.contraception.2023.109992.
     PubMed     Abstract available
     
     
     
222. THORNTON M, Arora KS
     Reproductive Justice in Post-Roe America: Impact of Restricted Abortion Access on Patients Seeking Permanent Contraception.
     Contraception. 2023 Feb 24:109995. doi: 10.1016/j.contraception.2023.109995.
     PubMed     Abstract available
     
     
     
223. EDMONDSON S, Conrado AB, Loria H, McLeigh J, et al
     Caregivers of youth in foster care in Texas and their role in contraception decision-making for adolescents in care.
     Contraception. 2023 Feb 23:109993. doi: 10.1016/j.contraception.2023.109993.
     PubMed     Abstract available
     
     
     
224. THOMPSON EL, Galvin AM, Ashvita Garg M, Diener A, et al
     A Socioecological Perspective to Contraceptive Access for Women Experiencing Homelessness in the United States.
     Contraception. 2023 Feb 23:109991. doi: 10.1016/j.contraception.2023.109991.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Contraception and Contraceptive Drugs is free of charge.